Issue Date: April 4, 2011
TB Alliance Signs China Research Deal
The nonprofit Global Alliance for TB Drug Development has signed an agreement with the International Scientific Exchange Foundation of China to discover and develop affordable and fast-acting drugs against tuberculosis. The two organizations will set up the Global Health R&D Center of China to develop treatments for public health diseases, including tuberculosis, malaria, and HIV/AIDS. The partners say GHRC will be the first Chinese not-for-profit product development partnership.
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society